Autopsy report · NCT00570531

Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma

“The study was unable the accrue the required number of patients within a reasonable time.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months after it had already started.
• Ran for about 6 years before it stopped.
• 6 participants enrolled.
• Results were posted on the registry 1 year 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

University of Michigan Rogel Cancer Center

Sponsor type

University, hospital or other

Conditions

Loco-regional Esophageal Cancer

Interventions

Bevacizumab; Paclitaxel; Cisplatin; 5-Fluorouracil; Radiation Therapy; Esophagectomy

Participants

6

Trials that died the same way

• Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection
  “Unable to accrual total number of participants during study period.” (73% match in meaning)
• Midfoot Fusion Bolt (MFB) in the Early Stage of Diabetic-neuropathic Charcot Feet
  “The study was stopped because there were not enough eligible patients to complete the study.” (70% match in meaning)
• Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients
  “Unable to enroll and study intended patient population.” (69% match in meaning)
• Intraoperative Methadone Administration for Improved Pain Control in Spinal Fusion Patients
  “Due to personnel loss and logistical issues the study was unable to be completed as planned.” (68% match in meaning)
• Efficacy of Rituximab in Acute Cellular Rejection in Renal Transplant Patients
  “The planned recruitment number of 180 Patient could not been achieved.” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.